Investing Profile

Ben Scruggs

InvestorVC
Partner at Hatteras Venture Partners
hatterasvp.comRaleigh-Durham / Southeast US
Photo of Ben Scruggs, Partner at Hatteras Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Moving Capital Network
963 CONNECTIONS
Vanderbilt University Network
112 CONNECTIONS
National Institutes of Health Network
32 CONNECTIONS
Hatteras Venture Partners Network
13 CONNECTIONS
Hatteras Venture Partners Network
13 CONNECTIONS
cb
$100K - $5.0M
$1.5M
2
$94M
CompanyStageDateRound SizeTotal Raised
Veralox Therapeutics
Series UnknownJun 2023$24M
Series AJun 2021$17M
$46M
Co-investors: Katie Ellias (T1D Fund)
Summer research intern LSU Health New Orleans School of NursingPresent
Undergraduate research Vanderbilt University Medical CenterPresent
Summer Research Intern National Institutes of HealthPresent
Postdoctoral Fellow National Institute of Environmental Health Sciences (NIEHS)Present
Hatteras Fellow Hatteras Venture PartnersPresent
Analyst Hatteras Venture PartnersPresent
Associate Hatteras Venture PartnersPresent
Manager Moving CapitalPresent
Manager L2 VenturesPresent
Board Member IMMvention Therapeutix, Inc.Present
Principal Hatteras Venture PartnersPresent
Board Member Veralox TherapeuticsPresent
Sr. Director, Strategic Initiatives Tune TherapeuticsPresent
Board Member Altis BiosystemsPresent
Chairman & CEO Altis BiosystemsPresent
Partner Hatteras Venture PartnersPresent
Vanderbilt University B.E. Biomedical Engineering
Washington University School of Medicine in St. Louis PhD Molecular Cell Biology
Sign in with Google →
Sign in with Google →